BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 15, 2026
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Celia trial: data strong, analysts skeptical
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Apricus Biosciences to meet with Health Canada on Femprox
May 9, 2012
Isis begins phase II ISIS-APOCIIIRx study
May 7, 2012
Novel inhibitors of diacylglycerol O-acyltransferase 1 presented
May 7, 2012
Lexicon Pharmaceuticals receives funds to support phase II testing in type 1 diabetes
May 4, 2012
Novel Shp2 inhibitors developed in Germany
May 4, 2012
Transbuccal insulin film produces encouraging first-in-human results
May 4, 2012
Novel potential therapies for obesity discovered at Bristol-Myers Squibb
May 4, 2012
Azelon completes phase II study of nasal spray for osteoporosis
May 3, 2012
Enrollment complete in pivotal study of oral testosterone replacement therapy
May 3, 2012
E.U. grant issued to support development of drug for fetal growth restriction
May 2, 2012
Previous
1
2
…
567
568
569
570
571
572
573
574
575
…
1800
1801
Next
RSS